Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis.
about
Reactive oxygen generated by Nox1 triggers the angiogenic switchTumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancerThe evolution of endothelial regulatory paradigms in cancer biology and vascular repairThe treatment of advanced renal cell cancer with high-dose oral thalidomideFully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer.Heterogeneous vascular dependence of tumor cell populationsAnticancer drug targets: approaching angiogenesisAdipose tissue mass can be regulated through the vasculature.Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liverThe hemostatic system and angiogenesis in malignancy.Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumorsNeutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapyAngiogenesis, thrombospondin, and ductal carcinoma in situ of the breast.Vascular endothelial growth factor inhibitor-induced hypertension: basics for primary care providers.Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells in human renal cell carcinoma is a primary target for therapy by tyrosine kinase inhibitors.Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype.Bone marrow angiogenesis and progression in multiple myeloma: clinical significance and therapeutic approach.Tumor angiogenesis as a target for dietary cancer preventionAngiogenesis in non-small cell lung cancer. A new target for therapy.Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth.The aortic ring model of angiogenesis: a quarter century of search and discovery.ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer.Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.Vascular endothelial growth factor A (VEGF-A) mRNA expression levels decrease after menopause in normal breast tissue but not in breast cancer lesions.Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervixTumour angiogenesis: the relevance to surgeons.Androgen receptor is causally involved in the homeostasis of the human prostate endothelial cellPrognostic value of angiopoietin-2 for death risk stratification in patients with metastatic colorectal carcinoma.VEGF blockade inhibits angiogenesis and reepithelialization of endometrium.Tyrosine kinase inhibitors in pediatric malignancies.Dysfunctional endothelial cells directly stimulate cancer inflammation and metastasis.Delineation of VEGF-regulated genes and functions in the cervix of pregnant rodents by DNA microarray analysis.Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role?The prognostic significance of the preoperative full blood count after resection of colorectal liver metastases.Endothelial progenitor cells promote tumor growth and progression by enhancing new vessel formationProstacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner.Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.Low-dose metronomic cyclophosphamide treatment mediates ischemia-dependent K-ras mutation in colorectal carcinoma xenografts.Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy.
P2860
Q24292207-75A631FC-7B59-40B4-98EB-20F10D4EC188Q24652733-C70B3E1D-0488-4B43-8DB1-4BF7BE94F1EEQ26822678-4C9F9FBB-58FA-4DDF-AD9C-B2DCE86A67E2Q28361231-D0FEB9B2-DA19-40BE-AAC6-DD614642FA3AQ30752888-C2C86C76-CD7F-406E-8108-60B6939A11F3Q33181864-F288A952-C290-4C67-AC83-CFDDAF30798EQ33787870-FA47602E-FAAA-475A-B822-E2F8A7CD5680Q34075818-3650CC77-B01D-49B6-BD50-E17D71C8B043Q34382587-0405B1BA-37C8-4EFE-A892-515600B0EFE9Q34425462-51E6CC45-AFC9-4BD6-B4AA-51C5DC76518AQ34616563-92784DEC-AB77-43E1-A881-49071E3C2223Q34743875-5D4F73E1-4025-4C8F-9DFE-6D266E960E5FQ34766281-DA46A601-7E98-42DE-AF67-9CA31D8417BCQ34996468-75CC4AD2-ACAA-477E-AFF4-55FB1C54EE30Q35082185-FDBD7B3E-5350-427E-809C-FBFF6F9BD49CQ35088031-59EF36F4-33EF-4003-9395-A226E40517B3Q35128710-03349284-1AC9-4E05-95AA-1326C5EDEDEDQ35175287-C9EC47C4-A74F-444E-9687-435FF6AE9EEAQ35250910-4E79F7F7-6BBD-4EF3-91BF-E2435BA308D6Q35627784-D0138B6F-1418-4CFB-89AD-BAFCD5A9FDEFQ35788937-30CA57A8-6F87-483E-8C16-DEB71820FF07Q35832019-738593C6-9F19-439D-B78E-81B6CB2A01BAQ36060215-C00ED7B6-E8D0-4101-9F71-3B85B943C188Q36617784-0CBE88AA-17D0-4597-84D5-9B06AFF4714FQ36619626-4CC17A91-CFDA-4F29-BE2D-376BC059A3CEQ36621786-780D0CCF-8A72-44E9-86F6-BF7E65B20620Q36632396-22716455-FA8E-4D55-89EF-AD42E54304A3Q36692072-2A9C5CA6-D232-4497-89D0-9BA65B1F1763Q36724011-61DACB92-4532-4B3B-B3F9-67A1CA98185DQ36879461-03A52EED-8A5A-44DE-A8E4-962AC7947A86Q36977823-1B395542-ABD9-44A5-BDD3-450D88D22999Q37001253-1C0BFF2E-3F63-4638-9542-C97998EBB6B6Q37067054-A81F53C3-89A6-4ACA-B7AA-9FBCFC657362Q37286259-2C4B248A-5D30-4124-9484-AF70FA9CAC69Q37337938-91E74E89-738F-40EC-A921-423BA2E40DBEQ38905378-55238DEC-1D57-45DC-AFF7-55DE94CBD265Q39387572-8CC475AD-D17E-4365-9601-99E70EB16067Q39644572-4ED7AFE6-BBDA-4A21-B1BB-F7FF2F514136Q40020098-E4F32CD7-81C1-4DC5-AB85-83F34D6BF626Q40487782-419BF0DD-0E9D-45F4-B14D-7992CF2647E7
P2860
Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Reciprocal paracrine interacti ...... nesis progression' hypothesis.
@en
type
label
Reciprocal paracrine interacti ...... nesis progression' hypothesis.
@en
prefLabel
Reciprocal paracrine interacti ...... nesis progression' hypothesis.
@en
P2093
P1476
Reciprocal paracrine interacti ...... nesis progression' hypothesis.
@en
P2093
P304
P356
10.1016/S0959-8049(96)00396-6
P577
1996-12-01T00:00:00Z